Global Viscosupplementation Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers
31 May, 2023
The global viscosupplementation market size is expected to grow from $3.37 billion in 2022 to $3.73 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global viscosupplementation market size is expected to reach $5.36 billion in 2027 at a CAGR of 9.5%.
Global Viscosupplementation Market Key Driver
The rising prevalence of osteoarthritis is projected to boost the viscosupplementation industry ahead. Osteoarthritis is a degenerative joint condition, often known as a prevalent form of arthritis, in which the joints, primarily in the hips, knees, and hands, begin to break down. Viscosupplementation therapy reduces pain and facilitates smooth bone movement by injecting hyaluronic acid directly into the bone joints, which reduces pain and improves bone functionality.
Get a sample of the global viscosupplementation market reportGlobal Viscosupplementation Market Segments
The global viscosupplementation market is segmented:
1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
2) By Source: Avian Origin, Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
6) By Geography: The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global viscosupplementation market.
Major Viscosupplementation Industry Players
Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Sanofi S.A., Zimmer Biomet, Avanos Medical Inc., Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Teva Pharmaceutical Industries Ltd., Merck KGaA, Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A
Get the full global viscosupplementation market report
Viscosupplementation Market Overview
Viscosupplementation refers to a process where hyaluronic acid, a fluid that resembles gel, is injected straight into the joint. Synovial fluid around joints naturally contains hyaluronic acid, which helps lessen friction while moving.
Viscosupplementation Global Market Report 2023 provides data on the global viscosupplementation market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The viscosupplementation market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.